Proscar
$ 55,00 – $ 369,00Price range: $ 55,00 through $ 369,00
Prothiaden
$ 32,00 – $ 131,00Price range: $ 32,00 through $ 131,00
Proscare
$ 46,00 – $ 205,00Price range: $ 46,00 through $ 205,00
Proscare is an effective medication specifically designed to treat the symptoms of benign prostatic hyperplasia (BPH) in men. By inhibiting the production of a hormone responsible for prostate growth, it helps to shrink the enlarged gland over time. This process effectively eases urinary discomfort and improves the overall flow of urine for the user. Regular use of this treatment can significantly reduce the risk of acute urinary retention and the need for related surgical procedures. It provides a reliable solution for maintaining male urinary health and improving daily comfort.
Active substance: Finasteride
SKU:
Proscare
Category: Hair Loss
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Proscare belongs to a class of therapeutic agents known as 5-alpha reductase inhibitors. It is primarily prescribed for the management of symptomatic benign prostatic hyperplasia (BPH) in adult men with an enlarged prostate gland.
As a prescription-only medication regulated by the U.S. Food and Drug Administration (FDA), Proscare must be administered under qualified medical supervision. Diagnostic evaluation is required prior to initiating therapy to assess prostate volume and rule out alternative urological conditions, including prostate cancer.
| Parameter | Clinical Detail |
|---|---|
| Active Ingredient | Finasteride (5 mg) |
| Pharmacologic Class | 5-alpha reductase inhibitor |
| Primary Purpose | Treatment of Benign Prostatic Hyperplasia (BPH) |
| Dosage Form | Oral film-coated tablet |
| Route of Administration | Oral |
| Prescription Status | Prescription Only (Rx) |
How the Drug Works
The active component in Proscare acts as a competitive and specific inhibitor of the Type II 5-alpha reductase enzyme. Intracellularly, this enzyme is responsible for converting testosterone into the potent androgen dihydrotestosterone (DHT). Elevated intraprostatic levels of DHT contribute directly to hyperplastic growth of the prostatic parenchymal tissue.
By suppressing circulating and intraprostatic DHT levels by up to 70%, Proscare induces a progressive regression of prostate tissue volume. This reduction in glandular bulk alleviates mechanical obstruction at the bladder neck, resulting in improved urinary flow rates and a reduction in clinical symptoms associated with BPH over long-term administration.
Main Uses
Proscare is indicated for the treatment of symptomatic benign prostatic hyperplasia in men with enlarged prostates. Clinical objectives of therapy include improving urinary outflow, reducing night-time urination frequency (nocturia), decreasing hesitation during voiding, and lowering the long-term risk of acute urinary retention (AUR).
Additionally, therapy reduces the likelihood of requiring surgical interventions such as transurethral resection of the prostate (TURP). Off-label note: While lower strengths (1 mg) of the same active compound are prescribed for male pattern hair loss (androgenetic alopecia), the 5 mg formulation of Proscare is not FDA-indicated for hair loss therapy and should not be repurposed without specific clinical authorization.
Dosing Schedule
The standard dosage for adult males is one 5 mg tablet taken orally once daily. Proscare may be taken with or without food. Daily dosing should be maintained consistently to preserve steady-state enzymatic suppression.
Physicians generally evaluate treatment efficacy over an extended period. Although symptomatic improvement may be observed within a few weeks, continuous administration for at least six months is typically required to assess whether a satisfactory therapeutic response has been achieved. Dosage adjustments are not necessary for elderly patients or individuals with varying degrees of renal insufficiency.
How It’s Absorbed and Eliminated
Following oral administration, maximum plasma concentration (Cmax) of the drug is attained approximately 1 to 2 hours post-dose. The average systemic bioavailability of oral tablets is approximately 63% to 80%, unaffected by concurrent food intake. The drug demonstrates high plasma protein binding, estimated at approximately 90%.
Metabolism occurs extensively in the liver, primarily mediated via the cytochrome P450 3A4 (CYP3A4) enzyme system, producing two major inactive metabolites. Excretion occurs via dual pathways: approximately 57% of the dose is excreted in feces and 39% is excreted in urine as metabolites. The mean terminal elimination half-life in healthy adult males is approximately 6 hours, which may extend slightly to 8 hours in individuals aged 70 years and older.
Adverse Reactions
Clinical trials indicate that adverse reactions associated with Proscare are primarily related to lower androgenic activity. The most commonly reported side effects include erectile dysfunction, decreased libido, and a reduction in ejaculate volume. These occurrences generally develop early in the treatment course and often resolve with continued therapy or discontinuation of the medication.
Less frequent adverse reactions include breast tenderness, gynecomastia (breast enlargement), testicular pain, and hypersensitivity reactions such as localized skin rash, pruritus, or facial swelling. Clinical warnings also highlight potential persistent sexual dysfunction and depressive symptoms post-discontinuation, requiring prompt consultation with a healthcare provider if observed.
Compatibility With Other Medicines
Pharmacokinetic interaction studies have shown no clinically significant drug interactions when co-administered with compounds evaluated in trial settings, including antipyrine, digoxin, propranolol, theophylline, and warfarin. Although the drug undergoes CYP3A4-mediated metabolism, potent inhibitors or inducers of this pathway do not typically mandate specific dosage adjustments for Proscare.
Crucially, Proscare alters a major diagnostic biomarker: serum Prostate-Specific Antigen (PSA). Treatment reduces total baseline serum PSA concentrations by approximately 50% in patients with BPH. Healthcare providers must establish a new baseline PSA level after 6 months of therapy and double the measured PSA values when screening for potential prostate malignancy in treated individuals.
Important Precautions
Proscare is strictly contraindicated in female patients, pediatric individuals, and patients with known hypersensitivity to any formulation component. A major safety precaution involves pregnant women or women who may become pregnant. Due to the potential risk of transdermal absorption, women must not handle crushed or broken tablets containing this active substance, as inhibition of 5-alpha reductase can cause developmental abnormalities in male fetal genitalia.
Prior to initiating therapy, clinicians must perform digital rectal examinations and appropriate evaluations to exclude prostate cancer or other severe urological diseases. Patients with severe hepatic impairment should be monitored closely due to the drug’s primary hepatic clearance pathway.
What to Avoid While Taking It
There are no specific dietary restrictions required during treatment, and tablets may be ingested independently of meal times. Alcohol consumption does not directly interact with the clearance or systemic distribution of the medication.
However, patients with BPH are advised to moderate heavy alcohol consumption, as excessive alcohol intake can act as a bladder irritant and worsen lower urinary tract symptoms, potentially counteracting the clinical benefits of the medication.
If You Skip a Dose
If a dose is missed, it should be skipped, and the standard dosing schedule resumed the following day at the regular time. Patients should not take double doses or extra tablets to make up for a missed administration.
Consistent daily administration is key to maintaining stable intraprostatic dihydrotestosterone suppression. Repeatedly missing doses will result in fluctuations in hormone levels and may diminish therapeutic outcomes over time.
Signs of Improvement
Evaluations of efficacy rely on objectifiable and subjectively reported parameters. Patients may observe a reduction in urinary urgency, decreased nocturnal awakenings, and a stronger, less interrupted urinary stream.
Because structural prostate involution relies on cellular apoptosis, physiological improvement is gradual. Urological reassessment, including uroflowmetry and residual volume measurements, typically takes place between 3 to 6 months after starting continuous daily therapy.
Storage and Expiration
Tablets should be stored at controlled room temperature, ideally between 20°C and 25°C (68°F to 77°F), with short excursions permitted between 15°C and 30°C (59°F and 86°F). Keep the medication inside its original container to protect it from light and excessive moisture.
Do not store the medication in high-humidity areas such as bathrooms. Ensure the product remains out of reach of children and pet animals, and safely dispose of any unused or expired tablets in accordance with federal and local pharmacy take-back guidelines.
Common Questions
How does Proscare impact PSA blood tests for prostate cancer screening?
Proscare reduces total serum Prostate-Specific Antigen (PSA) levels by approximately 50% after six months of continuous use. Prescribers must take this reduction into account when evaluating PSA results for prostate cancer detection, typically doubling the lab result value to compare against standard baseline thresholds.
Can women handle Proscare tablets safely?
Intact, film-coated tablets are safe to handle under normal conditions. However, women who are pregnant or planning to become pregnant must avoid touching broken or crushed tablets, as the active substance can be absorbed through the skin and poses serious risks of developmental defects to a male fetus.
Is it safe to stop taking Proscare abruptly if side effects occur?
Abruptly stopping the medication is not immediately dangerous, but intraprostatic DHT levels will return to baseline within several weeks, leading to a gradual recurrence of prostate tissue enlargement and urinary obstruction symptoms. Patients should discuss any side effects with their physician before altering their regimen.
Does Proscare cause permanent changes to sexual function?
In most patients, adverse sexual side effects resolve over time or disappear after stopping treatment. However, clinical post-marketing surveillance reports note that a small subset of patients have experienced persistent sexual dysfunction post-discontinuation. Any persistent symptoms should be formally evaluated by a physician.
Will Proscare lower serum testosterone levels in the body?
No, Proscare does not decrease circulating total testosterone levels. Instead, it prevents the specific enzymatic conversion of testosterone into dihydrotestosterone (DHT). In fact, serum testosterone levels may show a slight, clinically insignificant increase while remaining within normal physiological ranges.
In accordance with FDA requirements.
Information on this page is for reference and does not replace an assessment by a licensed healthcare professional.
Additional information
| Dosage |
5mg |
|---|---|
| Package |
30 pills ,60 pills ,90 pills ,120 pills ,180 pills ,270 pills ,360 pills |
| Ενεργός Ουσία |
Related products
Dutas
$ 57,00 – $ 464,00Price range: $ 57,00 through $ 464,00
Active substance: Dutasteride
More Details
This product has multiple variants. The options may be chosen on the product page
Finast
$ 78,00 – $ 540,00Price range: $ 78,00 through $ 540,00
Active substance: Finasteride
More Details
This product has multiple variants. The options may be chosen on the product page
Fincar
$ 68,00 – $ 176,00Price range: $ 68,00 through $ 176,00
Active substance: Finasteride
More Details
This product has multiple variants. The options may be chosen on the product page
Finpecia
$ 40,00 – $ 240,00Price range: $ 40,00 through $ 240,00
Active substance: Finasteride
More Details
This product has multiple variants. The options may be chosen on the product page
Morr F
$ 100,00 – $ 307,00Price range: $ 100,00 through $ 307,00
Active substance: Finasteride, Minoxidil
More Details
This product has multiple variants. The options may be chosen on the product page
Perfectil
$ 75,00 – $ 135,00Price range: $ 75,00 through $ 135,00
More Details
This product has multiple variants. The options may be chosen on the product page
Proscar
$ 55,00 – $ 369,00Price range: $ 55,00 through $ 369,00
Active substance: Finasteride
More Details
This product has multiple variants. The options may be chosen on the product page
Rogaine 2
$ 51,00 – $ 217,00Price range: $ 51,00 through $ 217,00
Active substance: Minoxidil
More Details
This product has multiple variants. The options may be chosen on the product page
